Egalognastat

N/A

Report date: 2025/06/20 16:55:58
NME

Base Information

Drug NameEgalognastat
Drug Alias NameASN-120290ASN-561ASN-90FNP-223FNP 223 +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein O-GlcNAcase inhibitors
TargetsProtein O-GlcNAcase
Therapy Area/IndicationsAlzheimer DiseaseSupranuclear Palsy, ProgressiveParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandPortugal +[9
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAsceneuron SA
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseSupranuclear Palsy, ProgressiveParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A